HouseMarketBook

22 Spring Edge, Halifax

Terraced house · Freehold · HX1 3BB

Sold for, February 2021£61,000No floor area on record

Sold for £61,000 in February 2021.

Indexed with the UK House Price Index for Calderdale, that sale is worth about £83,400 today. The 119 terraced houses counted in HX1 3 over the last 24 months sold for a median of £1,350 per square metre. No energy certificate matches this address, so there is no floor area and no price per square metre; its sold prices are shown in full.

Today's value£83,400
HX1 3 median, terraced house£1,350per m²

Sale history

HM Land Registry · 3 sales since 1995
DatePrice paid£ / m²Growth / yrAfter inflationToday's value
Feb 2021£61,000—+4.4%+2.3%£83,400
Nov 2004£30,000—+5.5%+3.7%£63,700
Nov 1995£18,550———£100,500

Growth is the compound annual rate between one sale and the next, shown when they are at least a year apart; after inflation uses CPIH for the same months. Today's value indexes each sale forward with the UK House Price Index for Calderdale to August 2026.

Recent sales in HX1 3

Newest first
AddressDatePriceSize£ / m²
35 Gibraltar AvenueSep 2026£150,00062 m²£2,420
23 Wilson RoadAug 2026£115,00079 m²£1,460
5 Elmfield TerraceAug 2026£365,000199 m²£1,830
49 Emscote AvenueAug 2026£140,00094 m²£1,490
120 Gibraltar RoadAug 2026£142,00058 m²£2,450
39 Haugh Shaw RoadJul 2026£220,000131 m²£1,680
37 Cromer StreetJul 2026£68,50056 m²£1,220
15 Mile Cross GardensJul 2026£130,00069 m²£1,880
25 Mayfield AvenueJul 2026£200,000107 m²£1,870
30 Moorfield StreetJul 2026£140,000130 m²£1,080
Everything in HX1 3

About this page

What did 22 Spring Edge sell for? 22 Spring Edge last sold for £61,000 in February 2021. HM Land Registry records 3 sales since 1995. Price per square metre is the price paid divided by that area; today's value indexes the latest sale forward with the UK House Price Index. None of these figures is a valuation.

Sales to September 2026 · HM Land Registry price paid data · MHCLG energy certificates · UK House Price Index to August 2026 · An index-based comparison of sold prices, not a valuation.